The Lancet The Lancet, Elsevier, 2018, 391 (10117), pp.219-229. ⟨10.1016/S0140-6736(17)32409-1⟩ Anand, S S, Bosch, J, Eikelboom, J W, Connolly, S J, Diaz, R, Widimsky, P, Aboyans, V, Alings, M, Kakkar, A K, Keltai, K, Maggioni, A P, Lewis, B S, Störk, S, Zhu, J, Lopez-Jaramillo, P, O'Donnell, M, Commerford, P J, Vinereanu, D, Pogosova, N, Ryden, L, Fox, K A A, Bhatt, D L, Misselwitz, F, Varigos, J D, Vanassche, T, Avezum, A A, Chen, E, Branch, K, Leong, D P, Bangdiwala, S I, Hart, R G, Yusuf, S & COMPASS Investigators 2018, ' Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease : an international, randomised, double-blind, placebo-controlled trial ', Lancet, vol. 391, no. 10117, pp. 219-229 . https://doi.org/10.1016/S0140-6736(17)32409-1 Anand, S S, Bosch, J, Eikelboom, J W, Connolly, S J, Diaz, R, Widimsky, P, Aboyans, V, Alings, M, Kakkar, A K, Keltai, K, Maggioni, A P, Lewis, B S, Störk, S, Zhu, J, Lopez-Jaramillo, P, O'Donnell, M, Commerford, P J, Vinereanu, D, Pogosova, N, Ryden, L, Fox, K A A, Bhatt, D L, Misselwitz, F, Varigos, J D, Vanassche, T, Avezum, A A, Chen, E, Branch, K, Leong, D P, Bangdiwala, S I, Hart, R G, Yusuf, S, COMPASS Investigators & Houlind, K C 2018, ' Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease : an international, randomised, double-blind, placebo-controlled trial ', Lancet, vol. 391, no. 10117, pp. 219-229 . https://doi.org/10.1016/S0140-6736(17)32409-1
Eikelboom, J W, Connolly, S J, Bosch, J, Dagenais, G R, Hart, R G, Shestakovska, O, Diaz, R, Alings, M, Lonn, E M, Anand, S S, Widimsky, P, Hori, M, Avezum, A, Piegas, L S, Branch, K R H, Probstfield, J, Bhatt, D L, Zhu, J, Liang, Y, Maggioni, A P, Lopez-Jaramillo, P, O'Donnell, M, Kakkar, A, Fox, K A A, Parkhomenko, A N, Ertl, G, Störk, S, Keltai, M, Ryden, L, Pogosova, N, Dans, A L, Lanas, F, Commerford, P J, Torp-Pedersen, C, Guzik, T J, Verhamme, P B, Vinereanu, D, Kim, J-H, Tonkin, A M, Lewis, B S, Felix, C, Yusoff, K, Steg, P G, Metsarinne, K P, Cook Bruns, N, Misselwitz, F, Chen, E, Leong, D, Yusuf, S & COMPASS Investigators 2017, ' Rivaroxaban with or without aspirin in stable cardiovascular disease ', New England Journal of Medicine, vol. 377, no. 14, pp. 1319-1330 . https://doi.org/10.1056/NEJMoa1709118 New England Journal of Medicine New England Journal of Medicine, Massachusetts Medical Society, 2017, 377 (14), pp.1319-1330. ⟨10.1056/NEJMoa1709118⟩ Eikelboom, J W, Connolly, S J, Bosch, J, Dagenais, G R, Hart, R G, Shestakovska, O, Diaz, R, Alings, M, Lonn, E M, Anand, S S, Widimsky, P, Hori, M, Avezum, A, Piegas, L S, Branch, K R H, Probstfield, J, Bhatt, D L, Zhu, J, Liang, Y, Maggioni, A P, Lopez-Jaramillo, P, O'Donnell, M, Kakkar, A K, Fox, K A A, Parkhomenko, A N, Ertl, G, Störk, S, Keltai, M, Ryden, L, Pogosova, N, Dans, A L, Lanas, F, Commerford, P J, Torp-Pedersen, C, Guzik, T J, Verhamme, P B, Vinereanu, D, Kim, J-H, Tonkin, A M, Lewis, B S, Felix, C, Yusoff, K, Steg, P G, Metsarinne, K P, Cook Bruns, N, Misselwitz, F, Chen, E, Leong, D, Yusuf, S, COMPASS Investigators & Houlind, K C 2017, ' Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease ', The New England Journal of Medicine, vol. 377, no. 14, pp. 1319-1330 . https://doi.org/10.1056/NEJMoa1709118 New England journal of medicine, 377(14), 1319-1330. Massachussetts Medical Society COMPASS Investigators 2017, ' Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease ', The New England Journal of Medicine, vol. 377, no. 14, pp. 1319-1330 . https://doi.org/10.1056/NEJMoa1709118
Connolly, S J, Eikelboom, J W, Bosch, J, Dagenais, G, Dyal, L, Lanas, F, Metsarinne, K, O'Donnell, M, Dans, A L, Ha, J-W, Parkhomenko, A N, Avezum, A A, Lonn, E, Lisheng, L, Torp-Pedersen, C, Widimsky, P, Maggioni, A P, Felix, C, Keltai, K, Hori, M, Yusoff, K, Guzik, T J, Bhatt, D L, Branch, K R H, Cook Bruns, N, Berkowitz, S D, Anand, S S, Varigos, J D, Fox, K A A, Yusuf, S & COMPASS investigators 2018, ' Rivaroxaban with or without aspirin in patients with stable coronary artery disease : an international, randomised, double-blind, placebo-controlled trial ', The Lancet, vol. 391, no. 10117, pp. 205-218 . https://doi.org/10.1016/S0140-6736(17)32458-3 Connolly, S J, Eikelboom, J W, Bosch, J, Dagenais, G, Dyal, L, Lanas, F, Metsarinne, K, O'Donnell, M, Dans, A L, Ha, J-W, Parkhomenko, A N, Avezum, A A, Lonn, E, Lisheng, L, Torp-Pedersen, C, Widimsky, P, Maggioni, A P, Felix, C, Keltai, K, Hori, M, Yusoff, K, Guzik, T J, Bhatt, D L, Branch, K R H, Cook Bruns, N, Berkowitz, S D, Anand, S S, Varigos, J D, Fox, K A A, Yusuf, S & COMPASS Investigators 2018, ' Rivaroxaban with or without aspirin in patients with stable coronary artery disease : an international, randomised, double-blind, placebo-controlled trial ', Lancet, vol. 391, no. 10117, pp. 205-218 . https://doi.org/10.1016/S0140-6736(17)32458-3 BASE-Bielefeld Academic Search Engine Connolly, S J, Eikelboom, J W, Bosch, J, Dagenais, G, Dyal, L, Lanas, F, Metsarinne, K, O'Donnell, M, Dans, A L, Ha, J-W, Parkhomenko, A N, Avezum, A A, Lonn, E, Lisheng, L, Torp-Pedersen, C, Widimsky, P, Maggioni, A P, Felix, C, Keltai, K, Hori, M, Yusoff, K, Guzik, T J, Bhatt, D L, Branch, K R H, Cook Bruns, N, Berkowitz, S D, Anand, S S, Varigos, J D, Fox, K A A, Yusuf, S, COMPASS Investigators & Houlind, K C 2018, ' Rivaroxaban with or without aspirin in patients with stable coronary artery disease : an international, randomised, double-blind, placebo-controlled trial ', Lancet, vol. 391, no. 10117, pp. 205-218 . https://doi.org/10.1016/S0140-6736(17)32458-3